ReP USP - Resultado da busca

Artigo de periodico
FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma (2024)
Torres, Lizeth Andrea Torres; Silva, Gabriel da ; Alves, Jovelina Samara Ferreira; Ushida, Tatiane Resende; Potenza, Júlia; Garcia, Cristiana Bernadelli ; Sousa, Lucas Oliveira ; Lopes, Norberto Peporine ; Almeida, Luciana Oliveira de; Leopoldino, Andréia Machado
Source: Journal Of Oral Pathology & Medicine. Unidade: FCFRP
Subjects: APOPTOSE, CARCINOMA DE CÉLULAS ESCAMOSAS, FARMACOTERAPIA, ANTINEOPLÁSICOS, NEOPLASIAS DE CABEÇA E PESCOÇO, NEOPLASIAS BUCAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TORRES, Lizeth Andrea Torres et al. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma. Journal Of Oral Pathology & Medicine, v. 53, n. 1, p. 42-52, 2024Tradução . . Disponível em: https://doi.org/10.1111/jop.13498. Acesso em: 08 out. 2025.
APA
Torres, L. A. T., Silva, G. da, Alves, J. S. F., Ushida, T. R., Potenza, J., Garcia, C. B., et al. (2024). FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma. Journal Of Oral Pathology & Medicine, 53( 1), 42-52. doi:10.1111/jop.13498
NLM
Torres LAT, Silva G da, Alves JSF, Ushida TR, Potenza J, Garcia CB, Sousa LO, Lopes NP, Almeida LO de, Leopoldino AM. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma [Internet]. Journal Of Oral Pathology & Medicine. 2024 ; 53( 1): 42-52.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/jop.13498
Vancouver
Torres LAT, Silva G da, Alves JSF, Ushida TR, Potenza J, Garcia CB, Sousa LO, Lopes NP, Almeida LO de, Leopoldino AM. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma [Internet]. Journal Of Oral Pathology & Medicine. 2024 ; 53( 1): 42-52.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/jop.13498
Artigo de periodico
In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment (2023)
Bezerra, Patrícia H. A.; Amaral, Cristina; Almeida, Cristina F.; Correia-da-Silva, Georgina; Torqueti, Maria Regina ; Teixeira, Natércia
Source: Molecules. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, FARMACOTERAPIA, ANTIOXIDANTES, NITRILAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEZERRA, Patrícia H. A. et al. In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment. Molecules, v. 28, n. 13, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3390/molecules28134893. Acesso em: 08 out. 2025.
APA
Bezerra, P. H. A., Amaral, C., Almeida, C. F., Correia-da-Silva, G., Torqueti, M. R., & Teixeira, N. (2023). In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment. Molecules, 28( 13), 1-14. doi:10.3390/molecules28134893
NLM
Bezerra PHA, Amaral C, Almeida CF, Correia-da-Silva G, Torqueti MR, Teixeira N. In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment [Internet]. Molecules. 2023 ; 28( 13): 1-14.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/molecules28134893
Vancouver
Bezerra PHA, Amaral C, Almeida CF, Correia-da-Silva G, Torqueti MR, Teixeira N. In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment [Internet]. Molecules. 2023 ; 28( 13): 1-14.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/molecules28134893
Artigo de periodico
Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs) (2023)
Berretta, Andresa Aparecida ; Lima, Jéssica Aparecida de; Falção, Soraia I.; Calhelha, Ricardo; Amorim, Nathaly Alcazar; Gonçalves, Isabella Salgado ; Zamarrenho, Luana Gonçalves; Barud, Hernane da Silva ; Bastos, Jairo Kenupp ; De Jong, David ; Vilas Boas, Miguel
Source: Molecules. Unidades: IQSC, FCFRP, FMRP, FFCLRP
Subjects: EXTRATOS (FORMAS FARMACÊUTICAS), PRÓPOLIS, ANTINEOPLÁSICOS, ANTIOXIDANTES, ANTI-INFLAMATÓRIOS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERRETTA, Andresa Aparecida et al. Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs). Molecules, v. 28, n. 20, p. 1-25, 2023Tradução . . Disponível em: https://doi.org/10.3390/molecules28207128. Acesso em: 08 out. 2025.
APA
Berretta, A. A., Lima, J. A. de, Falção, S. I., Calhelha, R., Amorim, N. A., Gonçalves, I. S., et al. (2023). Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs). Molecules, 28( 20), 1-25. doi:10.3390/molecules28207128
NLM
Berretta AA, Lima JA de, Falção SI, Calhelha R, Amorim NA, Gonçalves IS, Zamarrenho LG, Barud H da S, Bastos JK, De Jong D, Vilas Boas M. Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs) [Internet]. Molecules. 2023 ; 28( 20): 1-25.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/molecules28207128
Vancouver
Berretta AA, Lima JA de, Falção SI, Calhelha R, Amorim NA, Gonçalves IS, Zamarrenho LG, Barud H da S, Bastos JK, De Jong D, Vilas Boas M. Development and characterization of high-absorption microencapsulated organic propolis EPP-AF® extract (i-CAPs) [Internet]. Molecules. 2023 ; 28( 20): 1-25.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/molecules28207128
Artigo de periodico
Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds (2023)
Cacita, Natacha; Silva, Amanda Batista; Santos, Nicolle Azevedo Portela dos; Ramos, Loyanne Carla Barbosa; Del Lama, Maria Perpetua Freire de Morais; Naal, Rose Mary Zumstein Georgetto ; Nikolaou, Sofia
Source: ChemistrySelect. Unidades: FCFRP, FFCLRP
Subjects: ANTINEOPLÁSICOS, ANTI-HISTAMÍNICOS, RUTÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACITA, Natacha et al. Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds. ChemistrySelect, v. 8, n. 13, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1002/slct.202300285. Acesso em: 08 out. 2025.
APA
Cacita, N., Silva, A. B., Santos, N. A. P. dos, Ramos, L. C. B., Del Lama, M. P. F. de M., Naal, R. M. Z. G., & Nikolaou, S. (2023). Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds. ChemistrySelect, 8( 13), 1-11. doi:10.1002/slct.202300285
NLM
Cacita N, Silva AB, Santos NAP dos, Ramos LCB, Del Lama MPF de M, Naal RMZG, Nikolaou S. Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds [Internet]. ChemistrySelect. 2023 ; 8( 13): 1-11.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/slct.202300285
Vancouver
Cacita N, Silva AB, Santos NAP dos, Ramos LCB, Del Lama MPF de M, Naal RMZG, Nikolaou S. Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds [Internet]. ChemistrySelect. 2023 ; 8( 13): 1-11.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/slct.202300285
Artigo de periodico
The potential of phenothiazinium dyes as cytotoxicity markers in cisplatin-treated cells (2023)
Pereira, Luiz Miguel ; Portapilla, Gisele Bulhões ; Brancini, Guilherme Thomaz Pereira ; Possato, Bruna ; Costa, Cassia Mariana Bronzon da; Abreu-Filho, Péricles Gama ; Wainwright, Mark; Yatsuda, Ana Patrícia ; Braga, Gilberto Ubida Leite
Source: Scientific Reports. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, SOLVENTE, AZUL DE METILENO, COMPOSTOS ORGÂNICOS, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Luiz Miguel et al. The potential of phenothiazinium dyes as cytotoxicity markers in cisplatin-treated cells. Scientific Reports, v. 13, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-36721-0. Acesso em: 08 out. 2025.
APA
Pereira, L. M., Portapilla, G. B., Brancini, G. T. P., Possato, B., Costa, C. M. B. da, Abreu-Filho, P. G., et al. (2023). The potential of phenothiazinium dyes as cytotoxicity markers in cisplatin-treated cells. Scientific Reports, 13, 1-17. doi:10.1038/s41598-023-36721-0
NLM
Pereira LM, Portapilla GB, Brancini GTP, Possato B, Costa CMB da, Abreu-Filho PG, Wainwright M, Yatsuda AP, Braga GUL. The potential of phenothiazinium dyes as cytotoxicity markers in cisplatin-treated cells [Internet]. Scientific Reports. 2023 ; 13 1-17.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-023-36721-0
Vancouver
Pereira LM, Portapilla GB, Brancini GTP, Possato B, Costa CMB da, Abreu-Filho PG, Wainwright M, Yatsuda AP, Braga GUL. The potential of phenothiazinium dyes as cytotoxicity markers in cisplatin-treated cells [Internet]. Scientific Reports. 2023 ; 13 1-17.[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-023-36721-0
Artigo de periodico
Red propolis exhibits chemopreventive effect associated with antiproliferative and anti-inflammatory activities (2022)
Freitas, Karoline Soares de; Silva, Lucas Henrique Domingos da; Squarisi, Iara Silva; Oliveira, Lucas Teixeira de Souza; Ribeiro, Arthur Barcelos; Alves, Bianca Silva; Esperandim, Tábata Rodrigues; Melo, Matheus Reis Santos de; Ozelin, Saulo Duarte; Lemes, Danieli Cristina; Bastos, Jairo Kenupp ; Veneziani, Rodrigo Cassio Sola; Tavares, Denise Crispim
Source: Toxicology Research. Unidade: FCFRP
Subjects: ANTI-INFLAMATÓRIOS, ANTINEOPLÁSICOS, PRÓPOLIS, ISOFLAVONAS, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Karoline Soares de et al. Red propolis exhibits chemopreventive effect associated with antiproliferative and anti-inflammatory activities. Toxicology Research, v. 11, n. 5, p. 750-757, 2022Tradução . . Disponível em: https://doi.org/10.1093/toxres/tfac049. Acesso em: 08 out. 2025.
APA
Freitas, K. S. de, Silva, L. H. D. da, Squarisi, I. S., Oliveira, L. T. de S., Ribeiro, A. B., Alves, B. S., et al. (2022). Red propolis exhibits chemopreventive effect associated with antiproliferative and anti-inflammatory activities. Toxicology Research, 11( 5), 750-757. doi:10.1093/toxres/tfac049
NLM
Freitas KS de, Silva LHD da, Squarisi IS, Oliveira LT de S, Ribeiro AB, Alves BS, Esperandim TR, Melo MRS de, Ozelin SD, Lemes DC, Bastos JK, Veneziani RCS, Tavares DC. Red propolis exhibits chemopreventive effect associated with antiproliferative and anti-inflammatory activities [Internet]. Toxicology Research. 2022 ; 11( 5): 750-757.[citado 2025 out. 08 ] Available from: https://doi.org/10.1093/toxres/tfac049
Vancouver
Freitas KS de, Silva LHD da, Squarisi IS, Oliveira LT de S, Ribeiro AB, Alves BS, Esperandim TR, Melo MRS de, Ozelin SD, Lemes DC, Bastos JK, Veneziani RCS, Tavares DC. Red propolis exhibits chemopreventive effect associated with antiproliferative and anti-inflammatory activities [Internet]. Toxicology Research. 2022 ; 11( 5): 750-757.[citado 2025 out. 08 ] Available from: https://doi.org/10.1093/toxres/tfac049
Artigo de periodico
Antitumor activity of solamargine in mouse melanoma model: relevance to clinical safety (2022)
Furtado, Ricardo Andrade ; Ozelin, Saulo Duarte; Ferreira, Natália Helen; Miura, Bárbara Ayumi; Almeida Junior, Silvio; Magalhães, Geórgia M.; Nassar, Eduardo Jose; Miranda, Mariza Abreu; Bastos, Jairo Kenupp ; Tavares, Denise Crispim
Source: Journal of Toxicology and Environmental Health, Part A. Unidades: FCFRP, FFCLRP
Subjects: ANTINEOPLÁSICOS, PELE, NEOPLASIAS, SOLANACEAE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Ricardo Andrade et al. Antitumor activity of solamargine in mouse melanoma model: relevance to clinical safety. Journal of Toxicology and Environmental Health, Part A, v. 85, n. 4, p. 131-142, 2022Tradução . . Disponível em: https://doi.org/10.1080/15287394.2021.1984348. Acesso em: 08 out. 2025.
APA
Furtado, R. A., Ozelin, S. D., Ferreira, N. H., Miura, B. A., Almeida Junior, S., Magalhães, G. M., et al. (2022). Antitumor activity of solamargine in mouse melanoma model: relevance to clinical safety. Journal of Toxicology and Environmental Health, Part A, 85( 4), 131-142. doi:10.1080/15287394.2021.1984348
NLM
Furtado RA, Ozelin SD, Ferreira NH, Miura BA, Almeida Junior S, Magalhães GM, Nassar EJ, Miranda MA, Bastos JK, Tavares DC. Antitumor activity of solamargine in mouse melanoma model: relevance to clinical safety [Internet]. Journal of Toxicology and Environmental Health, Part A. 2022 ; 85( 4): 131-142.[citado 2025 out. 08 ] Available from: https://doi.org/10.1080/15287394.2021.1984348
Vancouver
Furtado RA, Ozelin SD, Ferreira NH, Miura BA, Almeida Junior S, Magalhães GM, Nassar EJ, Miranda MA, Bastos JK, Tavares DC. Antitumor activity of solamargine in mouse melanoma model: relevance to clinical safety [Internet]. Journal of Toxicology and Environmental Health, Part A. 2022 ; 85( 4): 131-142.[citado 2025 out. 08 ] Available from: https://doi.org/10.1080/15287394.2021.1984348
Artigo de periodico
Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition (2022)
Ozawa, Juliana Yumi Sakita; Elias-Oliveira, Jefferson; Sartori, Daniela Carlos; Santos, Emerson de Souza ; Almeida, Luciana Yamamoto de; Malta, Tathiane Maistro; Brunaldi, Mariângela Ottoboni; Albuquerque, Sérgio de ; Silva, Cleide Lúcia Araújo; Andrade, Marcus V.; Bonato, Vânia Luiza Deperon; Garcia, Sérgio Britto; Cunha, Fernando de Queiroz ; Cebinelli, Guilherme Cesar Martelossi; Martins Júnior, Ronaldo Bragança; Matthews, Jason; Colli, Leandro Machado ; Martin, Francis L.; Uyemura, Sergio Akira ; Kannen, Vinicius
Source: Journal for ImmunoTherapy of Cancer. Unidades: FMRP, FCFRP, PUSP-RP
Subjects: COLITE, NEOPLASIAS COLORRETAIS, ANTINEOPLÁSICOS, MASTÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OZAWA, Juliana Yumi Sakita et al. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition. Journal for ImmunoTherapy of Cancer, v. 10, n. 10, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1136/jitc-2022-004653. Acesso em: 08 out. 2025.
APA
Ozawa, J. Y. S., Elias-Oliveira, J., Sartori, D. C., Santos, E. de S., Almeida, L. Y. de, Malta, T. M., et al. (2022). Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition. Journal for ImmunoTherapy of Cancer, 10( 10), 1-15. doi:10.1136/jitc-2022-004653
NLM
Ozawa JYS, Elias-Oliveira J, Sartori DC, Santos E de S, Almeida LY de, Malta TM, Brunaldi MO, Albuquerque S de, Silva CLA, Andrade MV, Bonato VLD, Garcia SB, Cunha F de Q, Cebinelli GCM, Martins Júnior RB, Matthews J, Colli LM, Martin FL, Uyemura SA, Kannen V. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition [Internet]. Journal for ImmunoTherapy of Cancer. 2022 ; 10( 10): 1-15.[citado 2025 out. 08 ] Available from: https://doi.org/10.1136/jitc-2022-004653
Vancouver
Ozawa JYS, Elias-Oliveira J, Sartori DC, Santos E de S, Almeida LY de, Malta TM, Brunaldi MO, Albuquerque S de, Silva CLA, Andrade MV, Bonato VLD, Garcia SB, Cunha F de Q, Cebinelli GCM, Martins Júnior RB, Matthews J, Colli LM, Martin FL, Uyemura SA, Kannen V. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition [Internet]. Journal for ImmunoTherapy of Cancer. 2022 ; 10( 10): 1-15.[citado 2025 out. 08 ] Available from: https://doi.org/10.1136/jitc-2022-004653
Artigo de periodico
Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice (2022)
Puhl, Ana C.; Gomes, Giovanni Freitas; Damasceno, Samara; Fritch, Ethan J.; Levi, James A.; Johnson, Nicole J.; Scholle, Frank; Premkumar, Lakshmanane; Hurst, Brett L.; Lee-Montiel, Felipe; Veras, Flávio Protásio ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Moorman, Nathaniel J.; Yount, Boyd L.; Dickmander, Rebekah J.; Baric, Ralph S.; Pearce, Kenneth H.; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Ekins, Sean
Source: ACS Omega. Unidades: FCFRP, FMRP
Subjects: CORONAVIRUS, CITOCINAS, ANTINEOPLÁSICOS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice. ACS Omega, v. 7, p. 31935-31944, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsomega.2c02794. Acesso em: 08 out. 2025.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., et al. (2022). Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice. ACS Omega, 7, 31935-31944. doi:10.1021/acsomega.2c02794
NLM
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, Lee-Montiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander RJ, Baric RS, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice [Internet]. ACS Omega. 2022 ; 7 31935-31944.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.2c02794
Vancouver
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, Lee-Montiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander RJ, Baric RS, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice [Internet]. ACS Omega. 2022 ; 7 31935-31944.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acsomega.2c02794
Artigo de periodico
Efficient N-arylation of 4-chloroquinazolines en route to novel 4-anilinoquinazolines as potential anticancer agents (2021)
Nishimura, Rodolfo Hideki Vicente ; Santos, Thiago dos ; Murie, Valter Eduardo ; Furtado, Luciana Costa ; Costa-Lotufo, Letícia Veras ; Clososki, Giuliano Cesar
Source: Beilstein Journal of Organic Chemistry. Unidades: ICB, FCFRP
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, TECNOLOGIA DE MICRO-ONDAS, ADENOSINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NISHIMURA, Rodolfo Hideki Vicente et al. Efficient N-arylation of 4-chloroquinazolines en route to novel 4-anilinoquinazolines as potential anticancer agents. Beilstein Journal of Organic Chemistry, v. 17, p. 2968–2975, 2021Tradução . . Disponível em: https://doi.org/10.3762/bjoc.17.206. Acesso em: 08 out. 2025.
APA
Nishimura, R. H. V., Santos, T. dos, Murie, V. E., Furtado, L. C., Costa-Lotufo, L. V., & Clososki, G. C. (2021). Efficient N-arylation of 4-chloroquinazolines en route to novel 4-anilinoquinazolines as potential anticancer agents. Beilstein Journal of Organic Chemistry, 17, 2968–2975. doi:10.3762/bjoc.17.206
NLM
Nishimura RHV, Santos T dos, Murie VE, Furtado LC, Costa-Lotufo LV, Clososki GC. Efficient N-arylation of 4-chloroquinazolines en route to novel 4-anilinoquinazolines as potential anticancer agents [Internet]. Beilstein Journal of Organic Chemistry. 2021 ; 17 2968–2975.[citado 2025 out. 08 ] Available from: https://doi.org/10.3762/bjoc.17.206
Vancouver
Nishimura RHV, Santos T dos, Murie VE, Furtado LC, Costa-Lotufo LV, Clososki GC. Efficient N-arylation of 4-chloroquinazolines en route to novel 4-anilinoquinazolines as potential anticancer agents [Internet]. Beilstein Journal of Organic Chemistry. 2021 ; 17 2968–2975.[citado 2025 out. 08 ] Available from: https://doi.org/10.3762/bjoc.17.206
Artigo de periodico
Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity (2021)
Nunes, Paulo Sergio Gonçalves; Silva, Gabriel da ; Nascimento, Sofia; Mantoani, Susimaire Pedersoli; Andrade, Peterson de; Bernardes, Emerson Soares; Kawano, Daniel Fábio; Leopoldino, Andréia Machado ; Carvalho, Ivone
Source: Bioorganic Chemistry. Unidades: IPEN, FCFRP
Subjects: ANTINEOPLÁSICOS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, PROTEÍNAS QUINASES, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNES, Paulo Sergio Gonçalves et al. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity. Bioorganic Chemistry, v. 113, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2021.104982. Acesso em: 08 out. 2025.
APA
Nunes, P. S. G., Silva, G. da, Nascimento, S., Mantoani, S. P., Andrade, P. de, Bernardes, E. S., et al. (2021). Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity. Bioorganic Chemistry, 113. doi:10.1016/j.bioorg.2021.104982
NLM
Nunes PSG, Silva G da, Nascimento S, Mantoani SP, Andrade P de, Bernardes ES, Kawano DF, Leopoldino AM, Carvalho I. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity [Internet]. Bioorganic Chemistry. 2021 ; 113[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.bioorg.2021.104982
Vancouver
Nunes PSG, Silva G da, Nascimento S, Mantoani SP, Andrade P de, Bernardes ES, Kawano DF, Leopoldino AM, Carvalho I. Synthesis, biological evaluation and molecular docking studies of novel 1,2,3-triazole-quinazolines as antiproliferative agents displaying ERK inhibitory activity [Internet]. Bioorganic Chemistry. 2021 ; 113[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.bioorg.2021.104982
Artigo de periodico
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers (2021)
Di Filippo, Leonardo Delello; Azambuja, Juliana Hofstäter; Dutra, Jessyca Aparecida Paes; Luiz, Marcela Tavares ; Duarte, Jonatas Lobato; Nicoleti, Luiza Ribeiro; Saad, Sara Teresinha Olalla; Chorilli, Marlus
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, NEOPLASIAS CEREBRAIS, FARMACOCINÉTICA, FARMACOTERAPIA, SISTEMAS DE DISTRIBUIÇÃO DE MEDICAMENTOS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DI FILIPPO, Leonardo Delello et al. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2021.08.011. Acesso em: 08 out. 2025.
APA
Di Filippo, L. D., Azambuja, J. H., Dutra, J. A. P., Luiz, M. T., Duarte, J. L., Nicoleti, L. R., et al. (2021). Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics, 168, 76-89. doi:10.1016/j.ejpb.2021.08.011
NLM
Di Filippo LD, Azambuja JH, Dutra JAP, Luiz MT, Duarte JL, Nicoleti LR, Saad STO, Chorilli M. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 168 76-89.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ejpb.2021.08.011
Vancouver
Di Filippo LD, Azambuja JH, Dutra JAP, Luiz MT, Duarte JL, Nicoleti LR, Saad STO, Chorilli M. Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 168 76-89.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ejpb.2021.08.011
Artigo de periodico
Biosynthesis and characterization of gold nanoparticles using Brazilian red propolis and evaluation of its antimicrobial and anticancer activities (2021)
Botteon, Caroline Eloisa Apolinário ; Silva, Letícia Bueno; Ccana-Ccapatinta, Gari Vidal; Silva, T. S; Ambrosio, Sérgio Ricardo; Veneziani, R. C. S; Bastos, Jairo Kenupp ; Marcato, P. D
Source: Scientific Reports. Unidade: FCFRP
Subjects: NANOPARTÍCULAS, PRÓPOLIS, AGENTES ANTIMICROBIANOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOTTEON, Caroline Eloisa Apolinário et al. Biosynthesis and characterization of gold nanoparticles using Brazilian red propolis and evaluation of its antimicrobial and anticancer activities. Scientific Reports, v. 11, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-81281-w. Acesso em: 08 out. 2025.
APA
Botteon, C. E. A., Silva, L. B., Ccana-Ccapatinta, G. V., Silva, T. S., Ambrosio, S. R., Veneziani, R. C. S., et al. (2021). Biosynthesis and characterization of gold nanoparticles using Brazilian red propolis and evaluation of its antimicrobial and anticancer activities. Scientific Reports, 11( 1). doi:10.1038/s41598-021-81281-w
NLM
Botteon CEA, Silva LB, Ccana-Ccapatinta GV, Silva TS, Ambrosio SR, Veneziani RCS, Bastos JK, Marcato PD. Biosynthesis and characterization of gold nanoparticles using Brazilian red propolis and evaluation of its antimicrobial and anticancer activities [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-021-81281-w
Vancouver
Botteon CEA, Silva LB, Ccana-Ccapatinta GV, Silva TS, Ambrosio SR, Veneziani RCS, Bastos JK, Marcato PD. Biosynthesis and characterization of gold nanoparticles using Brazilian red propolis and evaluation of its antimicrobial and anticancer activities [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2025 out. 08 ] Available from: https://doi.org/10.1038/s41598-021-81281-w
Artigo de periodico
Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents (2021)
Gaspari, Ana Paula Segantin ; Silva, Roberto Santana da; Carneiro, Zumira Aparecida; Carvalho, Marcelo Rodrigues de; Carvalho, Ivone ; Pernomian, Laena ; Ferreira, Lucimara P.; Ramos, Loyanne Carla Barbosa; Souza, Gabriel Aguiar de; Formiga, André Luiz Barboza
Source: Anti-Cancer Agents in Medicinal Chemistry. Unidades: FCFRP, FMRP
Subjects: AMINOÁCIDOS, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPARI, Ana Paula Segantin et al. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, v. 21, n. 12, p. 1602-1611, 2021Tradução . . Disponível em: https://doi.org/10.2174/0929867327666201020155105. Acesso em: 08 out. 2025.
APA
Gaspari, A. P. S., Silva, R. S. da, Carneiro, Z. A., Carvalho, M. R. de, Carvalho, I., Pernomian, L., et al. (2021). Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, 21( 12), 1602-1611. doi:10.2174/0929867327666201020155105
NLM
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/0929867327666201020155105
Vancouver
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2025 out. 08 ] Available from: https://doi.org/10.2174/0929867327666201020155105
Artigo de periodico
Marine streptomyces sp. isolated from the brazilian endemic Tunicate Euherdmania sp. produces Dihydroeponemycin and analogs with potent antiglioma activity (2021)
Furtado, Luciana Costa ; Bauermeister, Anelize ; Felicio, Rafael de ; Ortega, Raquel; Pinto, Francisco das Chagas L. ; Machado Neto, João Agostinho ; Trivella, Daniela B. B. ; Pessoa, Otilia D. L. ; Wilke, Diego Veras ; Lopes, Norberto Peporine ; Jimenez, Paula C. ; Costa-Lotufo, Letícia Veras
Source: Frontiers in Marine Science. Unidades: ICB, FCFRP
Subjects: FARMACOLOGIA, PRODUTOS NATURAIS, QUIMIOTERÁPICOS, ANTINEOPLÁSICOS, STREPTOMYCES, EXTRATOS (FORMAS FARMACÊUTICAS), GLIOMA, INIBIDORES QUÍMICOS, CÉLULAS CULTIVADAS DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Luciana Costa et al. Marine streptomyces sp. isolated from the brazilian endemic Tunicate Euherdmania sp. produces Dihydroeponemycin and analogs with potent antiglioma activity. Frontiers in Marine Science, v. 8, p. 1-21, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmars.2021.644730. Acesso em: 08 out. 2025.
APA
Furtado, L. C., Bauermeister, A., Felicio, R. de, Ortega, R., Pinto, F. das C. L., Machado Neto, J. A., et al. (2021). Marine streptomyces sp. isolated from the brazilian endemic Tunicate Euherdmania sp. produces Dihydroeponemycin and analogs with potent antiglioma activity. Frontiers in Marine Science, 8, 1-21. doi:10.3389/fmars.2021.644730
NLM
Furtado LC, Bauermeister A, Felicio R de, Ortega R, Pinto F das CL, Machado Neto JA, Trivella DBB, Pessoa ODL, Wilke DV, Lopes NP, Jimenez PC, Costa-Lotufo LV. Marine streptomyces sp. isolated from the brazilian endemic Tunicate Euherdmania sp. produces Dihydroeponemycin and analogs with potent antiglioma activity [Internet]. Frontiers in Marine Science. 2021 ; 8 1-21.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fmars.2021.644730
Vancouver
Furtado LC, Bauermeister A, Felicio R de, Ortega R, Pinto F das CL, Machado Neto JA, Trivella DBB, Pessoa ODL, Wilke DV, Lopes NP, Jimenez PC, Costa-Lotufo LV. Marine streptomyces sp. isolated from the brazilian endemic Tunicate Euherdmania sp. produces Dihydroeponemycin and analogs with potent antiglioma activity [Internet]. Frontiers in Marine Science. 2021 ; 8 1-21.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fmars.2021.644730
Artigo de periodico
Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine (2021)
Leite, Marcel Nani; Viegas, Juliana Santos Rosa ; Praça, Fabíola ; Paula, Natália Aparecida de ; Ramalho, Leandra Naíra Zambelli; Bentley, Maria Vitória Lopes Badra ; Frade, Marco Andrey Cipriani
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, PELE, ANTINEOPLÁSICOS, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Marcel Nani et al. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine. European Journal of Pharmaceutical Sciences, v. 160, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.105769. Acesso em: 08 out. 2025.
APA
Leite, M. N., Viegas, J. S. R., Praça, F., Paula, N. A. de, Ramalho, L. N. Z., Bentley, M. V. L. B., & Frade, M. A. C. (2021). Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine. European Journal of Pharmaceutical Sciences, 160. doi:10.1016/j.ejps.2021.105769
NLM
Leite MN, Viegas JSR, Praça F, Paula NA de, Ramalho LNZ, Bentley MVLB, Frade MAC. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 160[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ejps.2021.105769
Vancouver
Leite MN, Viegas JSR, Praça F, Paula NA de, Ramalho LNZ, Bentley MVLB, Frade MAC. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 160[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.ejps.2021.105769
Artigo de periodico
Breast cancer targeting of a drug delivery system through postsynthetic modification of curcumin@N3-bio-MOF-100 via click chemistry (2021)
Alves, Renata C.; Schulte, Zachary M.; Luiz, Marcela Tavares; Silva, Patrícia Bento da; Frem, Regina C. G.; Rosi, Nathaniel L.; Chorilli, Marlus
Source: Inorganic Chemistry. Unidade: FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, PRODUTOS NATURAIS, AÇAFRÃO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Renata C. et al. Breast cancer targeting of a drug delivery system through postsynthetic modification of curcumin@N3-bio-MOF-100 via click chemistry. Inorganic Chemistry, v. 60, n. 16, p. 11739-11744, 2021Tradução . . Disponível em: https://doi.org/10.1021/acs.inorgchem.1c00538. Acesso em: 08 out. 2025.
APA
Alves, R. C., Schulte, Z. M., Luiz, M. T., Silva, P. B. da, Frem, R. C. G., Rosi, N. L., & Chorilli, M. (2021). Breast cancer targeting of a drug delivery system through postsynthetic modification of curcumin@N3-bio-MOF-100 via click chemistry. Inorganic Chemistry, 60( 16), 11739-11744. doi:10.1021/acs.inorgchem.1c00538
NLM
Alves RC, Schulte ZM, Luiz MT, Silva PB da, Frem RCG, Rosi NL, Chorilli M. Breast cancer targeting of a drug delivery system through postsynthetic modification of curcumin@N3-bio-MOF-100 via click chemistry [Internet]. Inorganic Chemistry. 2021 ; 60( 16): 11739-11744.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acs.inorgchem.1c00538
Vancouver
Alves RC, Schulte ZM, Luiz MT, Silva PB da, Frem RCG, Rosi NL, Chorilli M. Breast cancer targeting of a drug delivery system through postsynthetic modification of curcumin@N3-bio-MOF-100 via click chemistry [Internet]. Inorganic Chemistry. 2021 ; 60( 16): 11739-11744.[citado 2025 out. 08 ] Available from: https://doi.org/10.1021/acs.inorgchem.1c00538
Artigo de periodico
Antitumour anthracyclines: progress and perspectives (2020)
Martins-Teixeira, Maristela B.; Carvalho, Ivone
Source: ChemMedChem. Unidade: FCFRP
Subjects: QUIMIOTERÁPICOS, NEOPLASIAS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS-TEIXEIRA, Maristela B. e CARVALHO, Ivone. Antitumour anthracyclines: progress and perspectives. ChemMedChem, v. 15, n. 11, p. 933-948, 2020Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202000131. Acesso em: 08 out. 2025.
APA
Martins-Teixeira, M. B., & Carvalho, I. (2020). Antitumour anthracyclines: progress and perspectives. ChemMedChem, 15( 11), 933-948. doi:10.1002/cmdc.202000131
NLM
Martins-Teixeira MB, Carvalho I. Antitumour anthracyclines: progress and perspectives [Internet]. ChemMedChem. 2020 ; 15( 11): 933-948.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/cmdc.202000131
Vancouver
Martins-Teixeira MB, Carvalho I. Antitumour anthracyclines: progress and perspectives [Internet]. ChemMedChem. 2020 ; 15( 11): 933-948.[citado 2025 out. 08 ] Available from: https://doi.org/10.1002/cmdc.202000131
Artigo de periodico
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio (2020)
Pippa, Leandro Francisco ; Oliveira, Milena Locci de ; Rocha, Adriana; Andrade, Jurandyr Moreira de ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOCINÉTICA, VARIAÇÃO (BIOLOGIA), NEOPLASIAS MAMÁRIAS, MIOCARDIOPATIA CONGESTIVA, QUIMIOTERAPIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, v. 185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113231. Acesso em: 08 out. 2025.
APA
Pippa, L. F., Oliveira, M. L. de, Rocha, A., Andrade, J. M. de, & Lanchote, V. L. (2020). Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, 185. doi:10.1016/j.jpba.2020.113231
NLM
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Vancouver
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Artigo de periodico
Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents (2020)
Santos, Neife Aparecida Guinaim dos; Ferreira, Rafaela Scalco; Santos, Antônio Cardozo dos
Source: Food and Chemical Toxicology. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, NEOPLASIAS, QUIMIOTERAPIA, SISTEMA NERVOSO PERIFÉRICO, SISTEMA NERVOSO CENTRAL, MEDICAMENTO, PERDA AUDITIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Neife Aparecida Guinaim dos e FERREIRA, Rafaela Scalco e SANTOS, Antônio Cardozo dos. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food and Chemical Toxicology, v. 136, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.fct.2019.111079. Acesso em: 08 out. 2025.
APA
Santos, N. A. G. dos, Ferreira, R. S., & Santos, A. C. dos. (2020). Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food and Chemical Toxicology, 136. doi:10.1016/j.fct.2019.111079
NLM
Santos NAG dos, Ferreira RS, Santos AC dos. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents [Internet]. Food and Chemical Toxicology. 2020 ; 136[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.fct.2019.111079
Vancouver
Santos NAG dos, Ferreira RS, Santos AC dos. Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents [Internet]. Food and Chemical Toxicology. 2020 ; 136[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.fct.2019.111079

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration